Fragmentation in Europe’s banking markets is leading to lower returns for shareholders and higher borrowing costs, according ...

Cross Country Healthcare, Inc. (the “Company”) (Nasdaq: CCRN) announced today that it is scheduled to participate in the UBS Global Healthcare Confere ...

Tokyo’s core inflation is expected to come in at 1.7%, down from September’s 2%. The capital’s inflation is considered a ...

The 2024 Art Basel and UBS Survey of Global Collecting offers a fascinating glimpse into the ever-evolving world of ...

Consumer companies rallied after strong earnings from UPS boded well for consumer spending. Discount carrier Southwest Airlines struck a truce with activist investment firm Elliott Investment ...

“I’m far from trying to predict what’s going to happen,” UBS chief Sergio P. Ermotti told Semafor’s Liz Hoffman, at the World ...

With a focus on cancer and autoimmune conditions, UBS has launched its coverage of 13 small and mid-cap biotechs, noting that ...

The incipient migration of clients from Credit Suisse to UBS should take about another 18 months, UBS CEO Sergio Ermotti said ...

UBS raised the firm’s price target on eBay (EBAY) to $72 from $59 and keeps a Neutral rating on the shares ahead of the Q3 results on ...

In a report released today, Harry Blaiklock from UBS maintained a Hold rating on u-blox Holding AG (UBLXF – Research Report), with a ...

The median spending on art by wealthy collectors remains stable at around $50,000 a year, according to a recent survey.

Fintel reports that on October 24, 2024, UBS initiated coverage of Nuvalent (NasdaqGS:NUVL) with a Neutral recommendation.